These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transcriptional control of the human aldehyde dehydrogenase 2 promoter by hepatocyte nuclear factor 4: inhibition by cyclic AMP and COUP transcription factors. You M; Fischer M; Cho WK; Crabb D Arch Biochem Biophys; 2002 Feb; 398(1):79-86. PubMed ID: 11811951 [TBL] [Abstract][Full Text] [Related]
3. Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression. Jung D; Kullak-Ublick GA Hepatology; 2003 Mar; 37(3):622-31. PubMed ID: 12601360 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase-A dependent phosphorylation of transcription enhancer factor-1 represses its DNA-binding activity but enhances its gene activation ability. Gupta MP; Kogut P; Gupta M Nucleic Acids Res; 2000 Aug; 28(16):3168-77. PubMed ID: 10931933 [TBL] [Abstract][Full Text] [Related]
5. Polyunsaturated fatty acyl coenzyme A suppress the glucose-6-phosphatase promoter activity by modulating the DNA binding of hepatocyte nuclear factor 4 alpha. Rajas F; Gautier A; Bady I; Montano S; Mithieux G J Biol Chem; 2002 May; 277(18):15736-44. PubMed ID: 11864989 [TBL] [Abstract][Full Text] [Related]
6. Negative cyclic AMP response elements in the promoter of the L-type pyruvate kinase gene. Gourdon L; Lou DQ; Raymondjean M; Vasseur-Cognet M; Kahn A FEBS Lett; 1999 Oct; 459(1):9-14. PubMed ID: 10508908 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Huang W; Zhou X; Lefebvre V; de Crombrugghe B Mol Cell Biol; 2000 Jun; 20(11):4149-58. PubMed ID: 10805756 [TBL] [Abstract][Full Text] [Related]
8. The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4 alpha and cAMP-response element-binding protein (CREB). Louet JF; Hayhurst G; Gonzalez FJ; Girard J; Decaux JF J Biol Chem; 2002 Oct; 277(41):37991-8000. PubMed ID: 12107181 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the human cytochrome P4502D6 promoter. A potential role for antagonistic interactions between members of the nuclear receptor family. Cairns W; Smith CA; McLaren AW; Wolf CR J Biol Chem; 1996 Oct; 271(41):25269-76. PubMed ID: 8810289 [TBL] [Abstract][Full Text] [Related]
10. The G115S mutation associated with maturity-onset diabetes of the young impairs hepatocyte nuclear factor 4alpha activities and introduces a PKA phosphorylation site in its DNA-binding domain. Oxombre B; Kouach M; Moerman E; Formstecher P; Laine B Biochem J; 2004 Nov; 383(Pt. 3):573-80. PubMed ID: 15233628 [TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of the Atlantic salmon hepatocyte nuclear factor (HNF) 1 promoter by the orphan nuclear receptors HNF4 and chicken ovalbumin upstream promoter transcription factor I (COUP-TFI). McNair A; Cereghini S; Brand H; Smith T; Breillat C; Gannon F Biochem J; 2000 Dec; 352 Pt 2(Pt 2):557-64. PubMed ID: 11085951 [TBL] [Abstract][Full Text] [Related]
12. Effect of different basic helix-loop-helix leucine zipper factors on the glucose response unit of the L-type pyruvate kinase gene. Moriizumi S; Gourdon L; Lefrançois-Martinez AM; Kahn A; Raymondjean M Gene Expr; 1998; 7(2):103-13. PubMed ID: 9699482 [TBL] [Abstract][Full Text] [Related]
13. MODY1 mutation Q268X in hepatocyte nuclear factor 4alpha allows for dimerization in solution but causes abnormal subcellular localization. Sladek FM; Dallas-Yang Q; Nepomuceno L Diabetes; 1998 Jun; 47(6):985-90. PubMed ID: 9604881 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain. Sakamoto Y; Yoshida M; Semba K; Hunter T Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517 [TBL] [Abstract][Full Text] [Related]
15. Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Kawaguchi T; Takenoshita M; Kabashima T; Uyeda K Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13710-5. PubMed ID: 11698644 [TBL] [Abstract][Full Text] [Related]
16. HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). Stroup D; Chiang JY J Lipid Res; 2000 Jan; 41(1):1-11. PubMed ID: 10627496 [TBL] [Abstract][Full Text] [Related]
17. The mouse fetoprotein transcription factor (FTF) gene promoter is regulated by three GATA elements with tandem E box and Nkx motifs, and FTF in turn activates the Hnf3beta, Hnf4alpha, and Hnf1alpha gene promoters. Pare JF; Roy S; Galarneau L; Belanger L J Biol Chem; 2001 Apr; 276(16):13136-44. PubMed ID: 11145965 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation by hepatocyte nuclear factor-4 in a cell-free system derived from rat liver nuclei. Harish S; Khanam T; Mani S; Rangarajan P Nucleic Acids Res; 2001 Mar; 29(5):1047-53. PubMed ID: 11222753 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3. Sheridan CM; Heist EK; Beals CR; Crabtree GR; Gardner P J Biol Chem; 2002 Dec; 277(50):48664-76. PubMed ID: 12351631 [TBL] [Abstract][Full Text] [Related]
20. Activation of the insulin gene promoter through a direct effect of hepatocyte nuclear factor 4 alpha. Bartoov-Shifman R; Hertz R; Wang H; Wollheim CB; Bar-Tana J; Walker MD J Biol Chem; 2002 Jul; 277(29):25914-9. PubMed ID: 11994285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]